Press Releases

Contrast Enhanced Ultrasound Market is Anticipated to Grow US$ 3.80 Bn By 2030

Share This Article

According to the Vision Research Reports, the Global Contrast Enhanced Ultrasound market size was valued at USD 2.8 billion in 2020 and is projected to reach US$ 3.80 billion by 2030, growing at a CAGR of 8.0% from 2021 to 2030. 

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38408

Growth Factors

 Introduction of affordable dyes, increasing sonography procedural volume, and contrast imaging modes becoming an integral feature of ultrasound systems are the prominent factors driving the market.

The increasing prevalence of cardiovascular diseases, liver lesions, renal lesions, gastrointestinal diseases, and vascular diseases globally is anticipated to boost the market growth, as these are major areas of clinical application of Contrast-enhanced Ultrasound (CEUS) systems.

The presence of several potential benefits in CEUS such as being completely radiation-free, quick, cost-efficient, and patient-friendly, in comparison to the contrast-enhanced CT/MRI, is expected to propel the growth of the market.

Report Highlights

the equipment segment dominated the product segment with a market share of 92.6%. The introduction of advanced ultrasound units with transducer technology and nonlinear imaging techniques has simplified the workflow of CEUS, thereby fueling the market growth.

the non-targeted type segment dominated the CEUS market with a revenue share of over 83%. It is the most common method of the CEUS imaging technique. All the approved ultrasound contrast agents are of a non-targeted type.

The hospitals segment dominated the market and accounted for the largest revenue share of more than 68% in 2020. The increasing number of emergency visits with medical conditions, such as abdominal pain, abdominal/thoracic trauma, and cardiac complications, has led to the rising demand for CEUS in hospitals.

North America accounted for the largest market share of over 34% in 2020. CEUS imaging has been used in cardiac and abdominal imaging over the years in North America, but with its recent approval for characterization of liver lesions, it is gaining increased attention.

The clinics segment is anticipated to witness lucrative growth over the forecast period owing to the realization of economic and patient care benefits with the adoption of sonography devices in practice among physicians at primary and secondary care

In Asia Pacific, the market is expected to grow at the fastest rate owing to the limited accessibility to advanced CT/MRI imaging modalities such as CT and MRI, and the growing burden of cardiovascular disorders in China and India.

Report Coverage Details
Market Size US$ 3.80 billion by 2030
Growth Rate CAGR of 8.0% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, Type, End-use
Regional Scope North America, Latin America, Europe, Asia Pacific, MEA
Companies Mentioned Lantheus Medical Imaging, Inc.; Bracco Diagnostic, Inc.; General Electric; Siemens Healthcare GmbH; nanoPET Pharma GmbH; ESAOTE SPA; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Key Players

  • Lantheus Medical Imaging, Inc.
  • General Electric
  • Bracco Diagnostic
  • Siemens Healthcare GmbH
  • nanoPET Pharma GmbH
  • ESAOTE SPA
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Market Segmentation

  • Product Outlook
    • Equipment
    • Contrast Agent
  • Type Outlook
    • Non-targeted
    • Targeted
  • End-use Outlook
    • Hospitals
    • Clinics
    • Ambulatory Diagnostic Centers
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • Japan
      • India
      • Thailand
      • South Korea
    • Latin America
      •  Brazil
      •  Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38408

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Contrast Enhanced Ultrasound Market, By Product

7.1.  Contrast Enhanced Ultrasound Market, by Product, 2021-2030

7.1.1.    Equipment

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Contrast Agent

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Contrast Enhanced Ultrasound Market, By Type

8.1.  Contrast Enhanced Ultrasound Market, by Type, 2021-2030

8.1.1.    Non-targeted

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Targeted

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Contrast Enhanced Ultrasound Market, By End User

9.1.  Contrast Enhanced Ultrasound Market, by End User, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Clinics

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Ambulatory Diagnostic Centers

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Contrast Enhanced Ultrasound Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2016-2030)

10.1.2.  Market Revenue and Forecast, by Type (2016-2030)

10.1.3.  Market Revenue and Forecast, by End User (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.1.4.2.      Market Revenue and Forecast, by Type (2016-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.1.5.2.      Market Revenue and Forecast, by Type (2016-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2016-2030)

10.2.2.  Market Revenue and Forecast, by Type (2016-2030)

10.2.3.  Market Revenue and Forecast, by End User (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.4.2.      Market Revenue and Forecast, by Type (2016-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.5.2.      Market Revenue and Forecast, by Type (2016-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.6.2.      Market Revenue and Forecast, by Type (2016-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.7.2.      Market Revenue and Forecast, by Type (2016-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2016-2030)

10.3.2.  Market Revenue and Forecast, by Type (2016-2030)

10.3.3.  Market Revenue and Forecast, by End User (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.4.2.      Market Revenue and Forecast, by Type (2016-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.5.2.      Market Revenue and Forecast, by Type (2016-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.6.2.      Market Revenue and Forecast, by Type (2016-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.7.2.      Market Revenue and Forecast, by Type (2016-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2016-2030)

10.4.2.  Market Revenue and Forecast, by Type (2016-2030)

10.4.3.  Market Revenue and Forecast, by End User (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.4.2.      Market Revenue and Forecast, by Type (2016-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.5.2.      Market Revenue and Forecast, by Type (2016-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.6.2.      Market Revenue and Forecast, by Type (2016-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.7.2.      Market Revenue and Forecast, by Type (2016-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2016-2030)

10.5.2.  Market Revenue and Forecast, by Type (2016-2030)

10.5.3.  Market Revenue and Forecast, by End User (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.5.4.2.      Market Revenue and Forecast, by Type (2016-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.5.5.2.      Market Revenue and Forecast, by Type (2016-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2016-2030)

Chapter 11.  Company Profiles

11.1.              Lantheus Medical Imaging, Inc.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              General Electric

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Bracco Diagnostic

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Siemens Healthcare GmbH

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              nanoPET Pharma GmbH

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              ESAOTE SPA

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38408

Contact Us: 

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button